Jim Sheninger, GoodRx pharmacy strategy officer

GoodRx bets on work­ing with phar­ma­cies as pre­scrip­tion-drug re­im­burse­ment pres­sure grows

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

When GoodRx made its pub­lic de­but in 2020, the dig­i­tal health com­pa­ny built its busi­ness by work­ing with phar­ma­cy ben­e­fit man­agers, get­ting paid when cus­tomers used a PBM coupon to pay phar­ma­cies in cash rather than through in­sur­ance. But over the last year, it’s been shift­ing its mod­el to work more close­ly with phar­ma­cies, ne­go­ti­at­ing deals with them di­rect­ly rather than re­ly­ing sole­ly on PBMs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.